Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Maxim Group Downgrades Violin Memory (VMEM) to Hold
-
COPsync Announces Uplisting to NASDAQ and Pricing of $10.6 Million Underwritten Offering
-
Recon Technology, Ltd. Reports Fiscal Year 2016 First Quarter Financial Results
-
Notable Analyst Rating Changes 11/12: (M) (GALE) (DVN) Upgraded; (SUNE) (BSBR) (PWR) Downgraded
-
Pre-Open Stock Movers 11/12: (ANGI) (NTES) (GALE) Higher; (DSCI) (DGLY) (FRPT) Lower (more...)
-
Maxim Group Starts Eyegate Pharmaceuticals (EYEG) at Buy
-
Maxim Group Starts Mast Therapeutics (MSTX) at Buy
-
Maxim Group LLC Expands Regional and Community Bank Group With the Appointment of a Balance Sheet Strategist
-
Premier Holding Corp -- Update: Moving Forward on Our Plans
-
Maxim Group Downgrades MRC Global (MRC) to Hold
-
IsoRay (ISR) PT Lowered to $3 at Maxim Group
-
Medivation (MDVN) PT Lowered to $54 at Maxim Group; 'Buy' Maintained
-
OncoSec Medical Closes $7.5 Million Registered Direct Offering
-
Intec Pharma Reports Results for the Third Quarter of 2015
-
bluebird bio (BLUE) LentiGlobin 'Does Work', Maxim Group Says
-
Gladstone Capital Corporation Announces Exercise and Closing of Over-Allotment Option in Common Stock Offering
-
Gladstone Capital Corporation Announces Exercise and Closing of Over-Allotment Option in Common Stock Offering
-
Axion Power Completes Private Placement for $9 Million in Senior Convertible Notes with Warrants
-
Chipotle's E. coli outbreak threatens sales, emboldens critics
-
OncoSec Announces $7.5 Million Registered Direct Offering
-
Aeterna Zentaris (AEZS) Series B Warrantholders to Exercise Conversion
-
Aeterna Zentaris Announces Agreement to Exercise Substantially All Remaining Series B Warrants
-
Maxim Group Downgrades Seagate Technology (STX) to Hold
-
Applied DNA Sciences (APDN) Buy Rating Maintained at Maxim Group
-
Gilead Sciences (GILD) raises Revenue Guidance Following 3Q Beat; Maxim Group Reiterates Buy
-
Major European Beauty Player Entering U.S. Market
-
UPDATE: Maxim Group Downgrades Agenus Inc. (AGEN) to Hold
-
Pre-Open Stock Movers 10/27: (TRIV) (UQM) (BABA) Higher; (RRTS) (RCII) (MRVL) Lower (more...)
-
Gladstone Capital (GLAD) Prices 2M Common Stock Offering at $8.55/Share
-
Gladstone Capital Corporation Prices Common Stock Offering
-
After-Hours Movers 10/26: (TRIV) (IDTI) (EW) Higher; (RCII) (MRVL) (MSTR) Lower (more...)
-
Gladstone Capital (GLAD) Announces 2M Common Stock Offering
-
Gladstone Capital Corporation Announces Common Stock Offering
-
Gladstone Capital Corporation Announces Common Stock Offering
-
Notable Analyst Rating Changes 10/23: (AAPL) (ZSPH) (PACB) Upgraded; (UA) (TCK) (ENTA) Downgraded
-
NovaBay Pharma (NBY) Prices 12.3M Common Stock, Warrants Offering
-
NovaBay Announces Pricing of Public Offering of Common Stock and Warrants
-
Maxim Group Upgrades Apple (AAPL) to Buy
-
Maxim Group Starts CIBER (CBR) at Buy
-
Maxim Group Downgrades VMware (VMW) to Hold
-
Maxim Group Starts Rock Creek Pharmaceuticals (RCPI) at Buy
-
Western Digital's (WDC) Price Target Raised to $140 at Maxim Group
-
Notable Analyst Rating Changes 10/19: (ITRI) (NKE) (BWLD) Upgraded; (UBNT) (BWA) (CNP) Downgraded
-
Maxim Group Upgrades Darden Restaurants (DRI) to Buy
-
Maxim Group Upgrades Buffalo Wild Wings, Inc. (BWLD) to Buy
-
Blue Earth (BBLU) Enters $4M Registered Direct Offering of Common Stock, Warrants
-
Blue Earth Announces $4 Million Registered Direct Offering
-
Rock Creek Pharmaceuticals Announces Institutional Financing with Issuance of $20 Million of Convertible Notes
-
Cerecor (CERCU) IPO Prices at $6.50/Unit
-
Cerecor Announces Pricing of Initial Public Offering

